GleamWall
中文EN

CGC Canopy Growth Corp

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1737927 · Reporting currency CAD · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.7%
TTM net income YoY21.3%
TTM EPS YoY66.5%
Revenue 3-yr CAGR1.0%
Net income 3-yr CAGR—

Margins

Gross margin24.4%
Operating margin-54.2%
Net margin-87.8%
FCF margin-25.8%
EBITDA margin-47.5%

Returns

ROE-39.5%
ROA-25.4%
ROIC (approx.)-20.3%
Asset turnover0.29x

Leverage & solvency

Liabilities / assets38.5%
Debt / equity0.38x
Current ratio2.82x
Interest coverage-3.69x

Cash quality & payout

Operating cash flow / net income0.27x
Accruals ratio-18.6%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: CAD FY20262026-03-31FY20252025-03-31
Income statement
Revenue284.60M269.00M
Cost of revenue214.93M189.48M
Gross profit69.67M79.51M
R&D expense2.61M2.74M
SG&A expense159.98M169.63M
Operating income-161.66M-117.14M
Interest expense38.19M74.57M
Pretax income-262.88M-507.76M
Income tax23,0007.14M
Net income-262.91M-508.88M
EBITDA-142.63M-95.62M
EPS (basic)-0.88-4.73
EPS (diluted)-0.88-4.73
Weighted avg. shares (diluted)298.04M107.55M
Balance sheet
Cash & equivalents364.68M113.81M
Short-term investments017.66M
Receivables31.24M47.51M
Inventory110.51M96.37M
Current assets529.47M294.57M
PP&E, net316.49M293.52M
Goodwill55.69M46.04M
Intangibles92.41M87.20M
Total assets1.12B917.70M
Current liabilities158.44M103.05M
Short-term debt16.24M4.26M
Long-term debt217.12M299.81M
Total debt233.36M304.07M
Total liabilities421.14M439.13M
Shareholders' equity697.59M478.57M
Net debt-131.32M190.26M
Shares outstanding422.07M183.87M
Cash flow statement
Operating cash flow-63.81M-165.75M
Capital expenditure5.33M10.81M
Free cash flow-69.14M-176.56M
Investing cash flow-21.35M-47.79M
Financing cash flow332.41M148.66M
Depreciation & amortization19.03M21.52M
Stock-based compensation4.27M-4.21M

Free plan shows the latest 2 periods; Pro shows all 11 🔒

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.